Christiane Dings
Field of research
|
Curriculum vitae
Since 12/2015: Doctoral student Clinical Pharmacy, Saarland University, Saarbrücken and external doctoral student in the graduate research training program „PharMetrX - Pharmacometrics & Computational Disease Modelling“
12/2015: Licensed as pharmacist
05/2015 – 11/2015: Practical year und diploma, University of Iceland, Reykjavík and Saarland University, Saarbrücken
11/2014 – 04/2015: Practical year, Einhorn-Apotheke, Saarbrücken
04/2014 – 05/2015: Student/scientific assistant Clinical Pharmacy, Saarland University, Saarbrücken
01/2014 – 04/2014: Student assistant RpDoc® Solutions GmbH, Saarbrücken
10/2009 – 09/2014: Pharmacy studies, Saarland University, Saarbrücken
07/2009: Abitur, Gymnasium am Schloss, Saarbrücken
Manuscripts
Dings C, Selzer D, Bragazzi NL, Möhler E, Wenning M, Gehrke T, Richter E, Nonnenmacher A, Brinkmann F, Rothoeft T, Zemlin M, Lücke T, Lehr T. Effect of vaccinations and school restrictions on the spread of COVID-19 in different age groups in Germany. Infect Dis Model. 2024; 9(4):1250-1264. Dings C, Lehr T, Vojnar B, Gaik C, Koch T, Eberhart LHJ, Huljic-Lankinen S, Murst M, Kreuer S. Population kinetic/pharmacodynamic modelling of the haemodynamic effects of cafedrine/theodrenaline (Akrinor) under general anaesthesia. Br J Clin Pharmacol. 2024. doi:10.1111/bcp.16083 Türk D, Scherer N, Selzer D, Dings C, Hanke N, Dallmann R, Schwab M, Timmins P, Nock V, Lehr T. Significant impact of time-of-day variation on metformin pharmacokinetics. Diabetologia 2023. Rothoeft T, Brinkmann F, Maier C, Selzer D, Dings C, Kuehn A, Möhler E, Grote H, Nonnenmacher A, Wenning M, Zemlin M, Richter U, Lehr T, Lücke T. Motivations for adolescent COVID-19 vaccination: A comparative study of adolescent and caregiver perspectives in Germany. Children (Basel). 2023;10(12):1890. Dings C, Meiser P, Holzer F, Flegel M, Selzer D, Nagy E, Mösges R, Klussmann JP, Lehr T. Pharmacometric modeling of the impact of azelastine nasal spray on SARS-CoV-2 viral load and related symptoms in COVID-19 patients. Pharmaceutics 2022;14(10):2059. Dings C, Götz KM, Och K, Sihinevich I, Werthner Q, Smola S, Bliem M, Mahfoud F, Volk T, Kreuer S, Rissland J, Selzer D, Lehr T. Model-based analysis of SARS-CoV-2 infections, hospitalization and outcome in Germany, the federal states and districts. Viruses 2022;14(10):2114. Scherer N, Kurbasic A, Dings C, Mari A, Nock V, Hennige AM, Koivula RW, Laakso M, Siloaho M, McDonald TJ, Pavo I, Giordano GN, Hansen TH, Rutters F, Dekker JM, Jablonka B, Ruetten H, Pearson ER, Franks PW, Lehr T. The impact and correction of analysis delay and variability in storage temperature on the assessment of HbA1c from dried blood spots - an IMI DIRECT Study. Int J Proteom Bioinform 2019;4(1):7-13. Scherer N, Dings C, Böhm M, Laufs U, Lehr T. Alternative treatment regimens with the PCSK9 inhibitors alirocumab and evolocumab: a pharmacokinetic and pharmacodynamic modeling approach. J Clin Pharmacol 2017;57(7):846-54. |
Posters
Dings C, Scherer N, Freijer J, Nock V, Lehr T. Mathematical modeling of glucose, insulin and c-peptide during the OGTT in pre-diabetic subjects: a DIRECT study. 26th Population Approach Group Europe (PAGE) meeting, 2017, Budapest, Hungary. Dings C, Lehr T. Pharmacokinetic/pharmacodynamic modeling of acetylsalicylic acid and its major metabolite salicylic acid. 25th Population Approach Group Europe (PAGE) meeting, 2016, Lisbon, Portugal. Dings C, Schäftlein A, Lehr T. Predicting the impact of oral anticoagulants on the human coagulation pathway using a comprehensive systems pharmacology model. Annual meeting of the German Pharmaceutical Society (DPhG), 2014, Frankfurt (Main), Germany. |